Support statement: This work was funded in its entirety by a project grant awarded by the Chief Scientist's Office of the Scottish Government Health Dept (CZG/2/573). The funding source had no role in the study design, data collection, analysis, and interpretation, in preparation of the manuscript, or the decision to submit it for publication. ; Peer reviewed ; Publisher PDF
Support statement: This work was funded in its entirety by a project grant awarded by the Chief Scientist's Office of the Scottish Government Health Dept (CZG/2/573). The funding source had no role in the study design, data collection, analysis, and interpretation, in preparation of the manuscript, or the decision to submit it for publication. ; Peer reviewed ; Publisher PDF
In: Been , J V , Nurmatov , U , van Schayck , C P & Sheikh , A 2013 , ' The impact of smoke-free legislation on fetal, infant and child health: a systematic review and meta-analysis protocol ' , BMJ Open , vol. 3 , no. 2 , e002261 . https://doi.org/10.1136/bmjopen-2012-002261
Introduction: Second-hand smoke (SHS) exposure is estimated to kill 600 000 people worldwide annually. The WHO recommends that smoke-free indoor public environments are enforced through national legislation. Such regulations have been shown to reduce SHS exposure and, consequently, respiratory and cardiovascular morbidity. Evidence of particular health benefit in children is now emerging, including reductions in low birthweight deliveries, preterm birth and asthma exacerbations. We aim to comprehensively assess the impact of smoke-free legislation on fetal, infant and childhood outcomes. This can inform further development and implementation of global policy and strategies to reduce early life SHS exposure. Methods: Two authors will search online databases (1975-present; no language restrictions) of published and unpublished/in-progress studies, and references and citations to articles of interest. We will consult experts in the field to identify additional studies. Studies should describe associations between comprehensive or partial smoking bans in public places and health outcomes among children (0-12 years): stillbirth, preterm birth, low birth weight, small for gestational age, perinatal mortality, congenital anomalies, bronchopulmonary dysplasia, upper and lower respiratory infections and wheezing disorders including asthma. The Cochrane Effectiveness Practice and Organisational Care (EPOC)-defined study designs are eligible. Study quality will be assessed using the Cochrane 7domain- based evaluation for randomised and clinical trials, and EPOC criteria for quasiexperimental studies. Data will be extracted by two reviewers and presented in tabular and narrative form. Metaanalysis will be undertaken using random-effects models, and generic inverse variance analysis for adjusted effect estimates. We will report sensitivity analyses according to study quality and design characteristics, and subgroup analyses according to coverage of ban, age group and parental/maternal smoking status. Publication bias will be ...
In: Child abuse & neglect: the international journal ; official journal of the International Society for the Prevention of Child Abuse and Neglect, Volume 102, p. 104394
Objective: To systematically review international evidence on the effectiveness and cost-effectiveness of interventions targeting the mental health, wellbeing, and retention of child and family social workers and their impact on child and family outcomes.Method:Systematic review and narrative synthesis of quantitative comparative studies. Published or unpublished research was sought via 12 bibliographic databases, websites, contact with experts, and citation tracking. Studies in any language were eligible for inclusion. Quality was assessed using Cochrane appraisal tools.Results: Fifteen studies were identified from 24 papers. Three studies considered individual-level interventions, with mixed and inconclusive findings. Eleven considered organisational interventions, with mixed but more promising findings. One study considered community-level interventions, with positive findings but a serious risk of bias. Only one study considered costs.Conclusion: The quality of evidence overall does not warrant clear recommendations for services. Organisation-level interventions show some promise. Robust, high-quality interventional studies are needed.
In: Child abuse & neglect: the international journal ; official journal of the International Society for the Prevention of Child Abuse and Neglect, Volume 140, p. 106187
Abstract Identifying which approaches can effectively reduce the need for out-of-home care for children is critically important. Despite the proliferation of different interventions and approaches globally, evidence summaries on this topic are limited. This study is a scoping review using a realist framework to explore what research evidence exists about reducing the number of children and young people in care. Searches of databases and websites were used to identify studies evaluating intervention effect on at least one of the following outcomes: reduction in initial entry to care; increase in family reunification post care. Data extracted from papers included type of study, outcome, type and level of intervention, effect, mechanism and moderator, implementation issues and economic (EMMIE) considerations. Data were coded by: primary outcome; level of intervention (community, policy, organisation, family or child); and type of evidence, using the realist EMMIE framework. This is the first example of a scoping review on any topic using this framework. Evaluated interventions were grouped and analysed according to system-level mechanism. We present the spread of evidence across system-level mechanisms and an overview of how each system-level mechanism might reduce the number of children in care. Implications and gaps are identified.
To address uncertainties in the prevention and management of influenza in people with asthma, we performed a scoping review of the published literature on influenza burden; current vaccine recommendations; vaccination coverage; immunogenicity, efficacy, effectiveness and safety of influenza vaccines; and the benefits of antiviral drugs in people with asthma. We found significant variation in the reported rates of influenza detection in individuals with acute asthma exacerbations making it unclear to what degree influenza causes exacerbations of underlying asthma. The strongest evidence of an association was seen in studies of children. Countries in the European Union currently recommend influenza vaccination of adults with asthma; however, coverage varied between regions. Coverage was lower among children with asthma. Limited data suggest that good seroprotection and seroconversion can be achieved in both children and adults with asthma and that vaccination confers a degree of protection against influenza illness and asthma related morbidity to children with asthma. There were insufficient data to determine efficacy in adults. Overall, influenza vaccines appeared to be safe for people with asthma. We identify knowledge gaps and make recommendations on future research needs in relation to influenza in patients with asthma.
In: Dhami , S , Nurmatov , U , Pajno , G B , Fernandez-Rivas , M , Muraro , A , Roberts , G , Akdis , C , Alvaro-Lozano , M , Beyer , K , Bindslev-Jensen , C , Burks , W , du Toit , G , Ebisawa , M , Eigenmann , P , Knol , E , Makela , M , Nadeau , K C , O'Mahony , L , Papadopoulos , N , Poulsen , L , Sackesen , C , Sampson , H , Santos , A , van Ree , R , Timmermans , F & Sheikh , A 2017 , ' Erratum to : Allergen immunotherapy for IgE-mediated food allergy: Protocol for a systematic review (Clinical and Translational Allergy (2016) 6 (24) DOI:10.1186/s13601-016-0113-z) ' , Clinical and Translational Allergy , vol. 7 , 31 . https://doi.org/10.1186/s13601-017-0166-7
Unfortunately this article [1] was published with an error in the Funding section. The BM4SIT project is notacknowledged. This section should be corrected to the below: Funding EAACI and the BM4SIT project (Grant Number 601763) in the European Union's Seventh Framework ProgrammeFP7.
In: Dhami , S , Nurmatov , U , Roberts , G , Pfaar , O , Muraro , A , Ansotegui , I J , Calderon , M , Cingi , C , Demoly , P , Durham , S , van Wijk , R G , Halken , S , Hamelmann , E , Hellings , P , Jacobsen , L , Knol , E , Linnemann , D L , Lin , S , Maggina , V , Oude-Elberink , H , Pajno , G , Panwankar , R , Pastorello , E , Pitsios , C , Rotiroti , G , Timmermans , F , Tsilochristou , O , Varga , E-M , Wilkinson , J , Williams , A , Worm , M , Zhang , L & Sheikh , A 2017 , ' Erratum to : Allergen immunotherapy for allergic rhinoconjunctivitis: Protocol for a systematic review (Clinical and Translational Allergy (2016) 6 (12) DOI:10.1186/s13601-016-0099-6) ' , Clinical and Translational Allergy , vol. 7 , 29 . https://doi.org/10.1186/s13601-017-0168-5
Unfortunately this article [1] was published with an error in the Funding section. The BM4SIT project is not acknowledged. This section should be corrected to the below: Funding EAACI and the BM4SIT project (Grant Number 601763) in the European Union's Seventh Framework Programme FP7.